PDCD1 and neoplasm: Purified PD-1+ (exhausted) TILs were as efficient as PD-1– TILs in killing PD-L1– tumor cells in the presence of 100 pM of ImmTAC®, and the addition of anti-PD1 blocking antibody had no impact (Fig. 6b and c).